Tags
immunotherapy7d490880-f428-44b9-8bdb-c3106f53171a |
diagnosis0d6e973c-1344-4350-9e76-1a56fd4f9e7e |
breast cancer47bc533d-3463-4193-b1ab-3bfe37bec31e |
prognosis0d6e973c-1344-4350-9e76-1a56fd4f9e7e |
Tumor microenvironment923c926d-99b6-4b20-82f3-c43fca5a71f9 |
neuroblastoma0d6e973c-1344-4350-9e76-1a56fd4f9e7e |
bioinformatics0d6e973c-1344-4350-9e76-1a56fd4f9e7e |
colon cancer923c926d-99b6-4b20-82f3-c43fca5a71f9 |
drug delivery0d6e973c-1344-4350-9e76-1a56fd4f9e7e |
detection0d6e973c-1344-4350-9e76-1a56fd4f9e7e |
omics0d6e973c-1344-4350-9e76-1a56fd4f9e7e |
immunology7d490880-f428-44b9-8bdb-c3106f53171a |
Tumor immunology and immunotherapy7d490880-f428-44b9-8bdb-c3106f53171a |
drug discovery0d6e973c-1344-4350-9e76-1a56fd4f9e7e |
leukemia7d490880-f428-44b9-8bdb-c3106f53171a |
pediatric cancerfe7db53d-d834-42e9-b57f-42f8a447a910 |
liquid biopsiesf5841ca1-8230-4144-b3e6-24b4c853584d |
Clinical trial7d490880-f428-44b9-8bdb-c3106f53171a |
Skin cancer923c926d-99b6-4b20-82f3-c43fca5a71f9 |
nanotechnology664a932f-fca0-4131-a6c0-561bb9c4e3ef |
clinical cancer research7d490880-f428-44b9-8bdb-c3106f53171a |
Melanoma923c926d-99b6-4b20-82f3-c43fca5a71f9 |
radiotherapyadf985df-d11d-4704-946c-7ccc898f5e6d |
prostate cancer0d6e973c-1344-4350-9e76-1a56fd4f9e7e |
technology development0d6e973c-1344-4350-9e76-1a56fd4f9e7e |
brain cancer102ee14f-47f4-4c73-b12b-4cda550e8155 |
cancer cell biology923c926d-99b6-4b20-82f3-c43fca5a71f9 |
patient treatment7d490880-f428-44b9-8bdb-c3106f53171a |
care7d490880-f428-44b9-8bdb-c3106f53171a |
Ovarian cancere675ca6f-2e02-469a-91e5-2830a7f4f21f |
cervical cancere675ca6f-2e02-469a-91e5-2830a7f4f21f |
Extracellular Vesicles8fda57b9-0387-415d-8497-d5cfbaedce78 |
Signal transduction923c926d-99b6-4b20-82f3-c43fca5a71f9 |
big data0d6e973c-1344-4350-9e76-1a56fd4f9e7e |
Single cell transcriptomics0fc3e09a-f7c8-4b3e-90a7-851012155678 |
nanoparticles664a932f-fca0-4131-a6c0-561bb9c4e3ef |
patient experience7d490880-f428-44b9-8bdb-c3106f53171a |
signaling923c926d-99b6-4b20-82f3-c43fca5a71f9 |
liver cancercbd9d6f1-56da-4a1a-a801-1ee71eff4ea4 |
colorectal923c926d-99b6-4b20-82f3-c43fca5a71f9 |
multi-omics analysis28a0aba3-ed4f-41be-bc10-ca589d3ad165 |
PDX581811ab-d986-4928-b7eb-619b00e6ec27 |
transcriptomics68c2ae11-89e8-4ef5-a4ae-544095a9978a |
biomarker identification00150295-523e-4e2a-8e6e-3036a5987de5 |
Lung cancerb28caba7-a119-4594-ab28-080a20b68a59 |
Lymphoma102ee14f-47f4-4c73-b12b-4cda550e8155 |
mouse models36d0349c-3368-4d46-a166-ccfca4d342fc |
patient-derived xenografts581811ab-d986-4928-b7eb-619b00e6ec27 |
Skin cancer prevention923c926d-99b6-4b20-82f3-c43fca5a71f9 |
colorectal carcinogenesisd39a8132-73fd-4396-b8d1-43930ff573c6 |
epigenetics99177347-27e0-431d-8d5b-11e1fa0b5c0d |
glioblastoma6d1d6630-bc44-400b-9b88-a14ce9bed562 |
proteomics3fe7c213-6bd7-4d9a-ad16-5fd8b5280afd |
CAR T cellsb28caba7-a119-4594-ab28-080a20b68a59 |
head & neck cancer50c181b6-24d2-48a1-ba17-60ed441f78e2 |
Host-microbe interactions50c181b6-24d2-48a1-ba17-60ed441f78e2 |
Sarcoma102ee14f-47f4-4c73-b12b-4cda550e8155 |
Acute myeloid leukemia7d490880-f428-44b9-8bdb-c3106f53171a |
T-ALL9c43fa2f-c21c-4149-9da0-a5413bb04b5b |
Tumor immunology40966da4-5fb3-43ad-98d1-4e2d8f5c7def |
zebrafisha799fb18-b5b0-444d-b04e-6e102f1ff001 |
Acute Lymphoblastic Leukemiaadadf52e-77b8-4e8a-834a-f27a63cf9d50 |
nanobody4dcc7156-f499-4ea7-9bb0-42f1caac44c0 |
single cell analysis9280ead3-62c7-46fc-bf20-30679689d708 |
T-cell acute lymphoblastic leukemiaadadf52e-77b8-4e8a-834a-f27a63cf9d50 |
cancer cell development68c2ae11-89e8-4ef5-a4ae-544095a9978a |
cancer stem cells68c2ae11-89e8-4ef5-a4ae-544095a9978a |
EMT161c5428-7a29-4dc0-ad59-58ca15558ce2 |
Epigenomics08f502e8-4e76-48cc-a4b4-78ec96e31c40 |
inflammationd54bbd51-ea52-4aa2-b66b-26c8c55f5830 |
Metastasis88828821-b328-41bf-8943-7d200c6bdcd8 |
mycotoxinsd39a8132-73fd-4396-b8d1-43930ff573c6 |
quality of lifeba7db225-980c-4bf4-bb8c-9e93cc57f7bf |
spatial transcriptomics0d6e973c-1344-4350-9e76-1a56fd4f9e7e |
surgerybaaee1fc-2209-4ea4-801b-5b8a6f1cc163 |
dendritic cell therapy664a932f-fca0-4131-a6c0-561bb9c4e3ef |
immunogenic cell death923c926d-99b6-4b20-82f3-c43fca5a71f9 |
mass spectrometrybf408afd-738e-46db-8843-b8da06b6c0ef |
organoidsd55b9ab4-6ced-4f3c-8f0c-06838fcc285f |
peritoneal carcinomatosise675ca6f-2e02-469a-91e5-2830a7f4f21f |
cell death8c79b65e-110d-4ff6-a877-28eb00f15311 |
Genomics68c2ae11-89e8-4ef5-a4ae-544095a9978a |
grantsa4bb0619-791f-47fe-9722-1ecd12bc8a2f |
kidney cancerbb4f2d72-2b0b-449d-a53e-622a2e736650 |
pan-cancer0d6e973c-1344-4350-9e76-1a56fd4f9e7e |
precision oncologyf3ab7110-cd3f-4cd6-aef4-c19afd11979d |
preclinical animal models99177347-27e0-431d-8d5b-11e1fa0b5c0d |
tissue engineering341a7c8c-2104-4f8a-8fec-8423a4d1c301 |
biomarker3fe7c213-6bd7-4d9a-ad16-5fd8b5280afd |
CRISPR-Cas19e1e2da-0f1f-4e9a-9d82-25a1bbd6215a |
GMPf635d650-39ab-4cfc-8aad-d83c275510b8 |
Microbiotacf3ddfbf-4fbc-4bab-828b-528d4c531316 |
Biomarker discovery0fc3e09a-f7c8-4b3e-90a7-851012155678 |
cfDNAf5841ca1-8230-4144-b3e6-24b4c853584d |
checkpoint inhibitors63cd1123-96c1-46c3-93a2-ed7d7a86663e |
etiology0e0c7241-8a31-4bc5-b8e0-a3fc1e948f3d |
hepatocellular carcinomadb100c91-781b-4b3f-bae8-fb35c8023ef2 |
imagingc1d2e957-8003-4906-be17-bd955d936b5e |
machine learningcf95aab2-c1a7-4d3d-aba5-93b4525111cd |
Multiple myelomabd84c7c7-2a89-4ef5-aba5-3c7c30e8ace7 |
RNA sequencing0d6e973c-1344-4350-9e76-1a56fd4f9e7e |
tumor spheroiddbe22699-238b-46d5-91c4-8d916c5882a1 |
biobankfe7db53d-d834-42e9-b57f-42f8a447a910 |
cancer predispositionfe7db53d-d834-42e9-b57f-42f8a447a910 |
chemotherapycbcac5d7-8b48-4fab-b03e-e23eb484e1ee |
epidemiologyd39a8132-73fd-4396-b8d1-43930ff573c6 |
juvenile myelomonocytic leukemiaadadf52e-77b8-4e8a-834a-f27a63cf9d50 |
Metabolomics0e0c7241-8a31-4bc5-b8e0-a3fc1e948f3d |
microbiomecf3ddfbf-4fbc-4bab-828b-528d4c531316 |
next generation sequencinga799fb18-b5b0-444d-b04e-6e102f1ff001 |
population screeningaa46a927-0144-454e-b5a5-beef50d4769e |
T cells7d490880-f428-44b9-8bdb-c3106f53171a |
DNA methylationecf47376-ba0c-4c47-8520-c00c0f0e2a57 |
dogsdf96fa38-7b0f-4190-b9a4-5fa31c8262b4 |
Flow cytometry0fc3e09a-f7c8-4b3e-90a7-851012155678 |
glioma886c82ea-7621-4062-9fc3-cee8ae1b0d64 |
immunomodulators63cd1123-96c1-46c3-93a2-ed7d7a86663e |
in vivo imagingea1c5aab-9d39-444a-9786-d08bebc54b89 |
in vivo model9411a205-dffe-4cc9-9cce-5354d50e9845 |
mRNA vaccinationd5679322-c470-4903-9c0c-f5ec7c5ab2ac |
non-coding RNAf3d5b128-1e65-4667-94ed-6b5e2a77f05f |
Oncolunch417f3196-064d-4068-9b5e-32244125dadb |
polymers664a932f-fca0-4131-a6c0-561bb9c4e3ef |
psychosocial research84a3f996-157d-4448-966b-959e64534ce5 |
Targeted therapy102ee14f-47f4-4c73-b12b-4cda550e8155 |
thyroid cancer102ee14f-47f4-4c73-b12b-4cda550e8155 |
Triple negative breast cancerc52fd17f-90ef-4450-a2a8-83ee01e9414f |
artificial intelligence40966da4-5fb3-43ad-98d1-4e2d8f5c7def |
ATMPf635d650-39ab-4cfc-8aad-d83c275510b8 |
cancer vaccinationb486896d-fb50-42c9-b223-833e050465f8 |
CRISPR/Cas9e90f5024-24da-4831-b41b-d7fb8c276f3a |
dendritic cell9280ead3-62c7-46fc-bf20-30679689d708 |
diagnosticsb912e735-c654-447e-8b54-28aa6b33134d |
gene therapyd5679322-c470-4903-9c0c-f5ec7c5ab2ac |
Glucocorticoidsbd84c7c7-2a89-4ef5-aba5-3c7c30e8ace7 |
high-throughput screening43038492-0f07-4e49-94f7-8c9a2879c25c |
imaging-guided surgery316d21f3-0524-429b-b1b4-227c59b6fe9e |
intraperitoneal drug delivery4f3d88e1-961d-4a72-b76e-6fda40aebb91 |
LC-MS4dcc7156-f499-4ea7-9bb0-42f1caac44c0 |
liquid biopsy0d6e973c-1344-4350-9e76-1a56fd4f9e7e |
nanomedicine6351d995-f631-477b-95c4-082338751c00 |
pancreatic cancera799fb18-b5b0-444d-b04e-6e102f1ff001 |
theranosticsb912e735-c654-447e-8b54-28aa6b33134d |
veterinary oncology0594bed9-8ce1-4d5e-bfc9-806c18c1f29e |
Xenopus tropicalis19e1e2da-0f1f-4e9a-9d82-25a1bbd6215a |
biosensors5b221abd-7d7d-4bc1-a89e-86a0791d8180 |
bladder cancerbb4f2d72-2b0b-449d-a53e-622a2e736650 |
cancer survivorship84a3f996-157d-4448-966b-959e64534ce5 |
canine model316d21f3-0524-429b-b1b4-227c59b6fe9e |
desmoid tumors102ee14f-47f4-4c73-b12b-4cda550e8155 |
dietary carcinogensd39a8132-73fd-4396-b8d1-43930ff573c6 |
ferroptosis3321f00e-fa8e-4d24-8d38-749d0afd4b33 |
genetic predispositiona799fb18-b5b0-444d-b04e-6e102f1ff001 |
genome editing19e1e2da-0f1f-4e9a-9d82-25a1bbd6215a |
Glucocorticoid receptorbd84c7c7-2a89-4ef5-aba5-3c7c30e8ace7 |
glycosylation9b778b7a-bb9d-4889-80cc-35a6a9b17b6c |
health economics40966da4-5fb3-43ad-98d1-4e2d8f5c7def |
hereditary cancera799fb18-b5b0-444d-b04e-6e102f1ff001 |
long non-coding RNA0d6e973c-1344-4350-9e76-1a56fd4f9e7e |
Metastasis and the tumor microenvironmentbda16243-4cd6-4761-b89e-8447c373a2c6 |
microscopy7abbf5a5-f497-44f3-9bd0-a25f39ac4e16 |
PET6d1d6630-bc44-400b-9b88-a14ce9bed562 |
preventionb2dd900b-eb7e-4626-89b5-480db2b16990 |
psychosocial caree8898110-af14-4002-8866-be53e0d20fab |
single cell9280ead3-62c7-46fc-bf20-30679689d708 |
small animal imaging95848056-0534-443f-bca8-93a2e14b7223 |
spatial proteomics581f372a-8da8-4df8-9517-7a5454dc35cc |
splicing13d6a058-6588-48be-822c-1b6796c57a3b |
squamous cell carcinoma0d920f63-13fc-4fac-8715-1dfcc9e0bbe2 |
Transcriptional Regulationb4459e1b-67af-4d12-83b9-4c37315c7ddf |
ultrasoundab9886dd-2896-4797-befb-13d7fe84a4d2 |
3D printing0f9554d4-8513-4a55-be10-ef94ef228f9e |
angiogenesis4882fe70-aba0-4ed8-9752-09766d586956 |
cancer immunotherapy1ce6fa23-4416-457f-9b52-f1f4f6c010ab |
cell death mechanisms923c926d-99b6-4b20-82f3-c43fca5a71f9 |
Cell therapycb82419f-5acd-468c-bb58-90cd3f569a83 |
cost-effectivenessff5ee05a-14df-47e7-a840-c012229642ff |
cytokinesd54bbd51-ea52-4aa2-b66b-26c8c55f5830 |
DNA repaira799fb18-b5b0-444d-b04e-6e102f1ff001 |
drug screeningdbe22699-238b-46d5-91c4-8d916c5882a1 |
Exosomes8fda57b9-0387-415d-8497-d5cfbaedce78 |
germ free technology1abf2e50-68d6-4caf-a4cd-fcbd130b2e76 |
germline and somatic mutation detectiona799fb18-b5b0-444d-b04e-6e102f1ff001 |
Glucocorticoid resistancebd84c7c7-2a89-4ef5-aba5-3c7c30e8ace7 |
Glycomicsf57fb4d5-f2d9-4ab0-8f65-4e3f916e1691 |
gnotobiotic micecf3ddfbf-4fbc-4bab-828b-528d4c531316 |
Humanized mice9892209a-37b7-441c-b5a7-55ddf1fe422e |
hydrogels5790b7b7-e5e7-4f80-a7a2-1a00eb586bcd |
ICP-mass spectrometry87a47972-f22d-4e1a-bd75-4cbb405b6667 |
immuno-oncology739f0456-34fe-4716-8f67-42a0be2e1038 |
laser capture microdissection7484abc2-4697-4ba3-87d0-4c8c00a697d7 |
macrophages9280ead3-62c7-46fc-bf20-30679689d708 |
Medicinal chemistryb3ece6b3-6c84-4294-8f67-9afbe9441891 |
MRI6d1d6630-bc44-400b-9b88-a14ce9bed562 |
neoantigensf635d650-39ab-4cfc-8aad-d83c275510b8 |
nutritiond55b9ab4-6ced-4f3c-8f0c-06838fcc285f |
OncoPointd0519574-1737-4ebd-ab35-afb01b1b206e |
pediatric acute myeloid leukemiaadadf52e-77b8-4e8a-834a-f27a63cf9d50 |
peritoneume675ca6f-2e02-469a-91e5-2830a7f4f21f |
personalized medicineba7db225-980c-4bf4-bb8c-9e93cc57f7bf |
photoporation01de78c1-051b-4510-b4ce-e71de6dfc5ad |
rehabilitation84a3f996-157d-4448-966b-959e64534ce5 |
siRNA81bdab74-da7c-4aff-9e13-f3ec5883052e |
structural biology871ab459-ce5b-4263-8996-67e59314dea3 |
therapy resistance88828821-b328-41bf-8943-7d200c6bdcd8 |
(3D) in vitro modelsab810780-75e2-4200-ae1a-c94d1797b20b |
3D models0c7c3d13-8069-4e8d-9d96-16d42d9b20df |
AMLe1414a32-f92b-4698-8ebc-dfc837244ef1 |
antisense oligonucleotidesf3d5b128-1e65-4667-94ed-6b5e2a77f05f |
Apoptosis923c926d-99b6-4b20-82f3-c43fca5a71f9 |
asparaginase2152f611-e7ae-4395-9be2-d171b9c2ea3c |
Bacterial Extracellular Vesicles4d03fe61-45fd-41db-a8cf-233fdb7ba6ab |
biomaterialsf3baf8fc-053e-4193-9bd8-dda6030c000a |
blood-brain barriere80a6917-97ef-42b4-bba1-031525972431 |
CAM89edd557-2ac6-44fe-8ad3-171cf78b0255 |
cancer-associated fibroblasts964e2443-cb66-4a87-9976-59c43581be7f |
cell migrationbe751e27-d43d-4b44-bd57-11de4408586c |
circulating tumor markers4c7457a5-6f55-4a62-9523-2d97ceeab06b |
DNA adductomics0e0c7241-8a31-4bc5-b8e0-a3fc1e948f3d |
drug testingc2ade4a8-4196-4ccb-a419-696ca19b2d0f |
Epithelial mesenchymal transitione185bf8a-faaf-47fd-bc89-cbce08520d02 |
equine cancer25882b4e-45da-44d2-8663-0f5fb93e1907 |
esophageal cancer80d74a39-d94b-4bda-a979-bc7d4fffde79 |
exposomec2a0faa8-3d1d-4f87-a90e-50ee4be1237e |
FWO1d74b6bc-ec02-46c1-bebc-6c3dbd766712 |
FWO1d74b6bc-ec02-46c1-bebc-6c3dbd766712 |
gynaecological cancer41131d7d-858b-4076-bbc8-faefd821fcbd |
health technology assessment25ac1c5d-63fe-4048-a288-468df4d5b49d |
hematopoiesis82fc6f79-4140-4f91-abe8-c3c332383e1a |
High resolution mass spectrometry0e0c7241-8a31-4bc5-b8e0-a3fc1e948f3d |
high-content screeningc1d2e957-8003-4906-be17-bd955d936b5e |
induced pluripotent stem cellsc1251d10-4998-4dd6-b441-2cb20cf33040 |
intracellular deliveryd037c813-b813-4682-a07f-9528a9c6480b |
Intraperitoneal Chemotherapydb100c91-781b-4b3f-bae8-fb35c8023ef2 |
lncRNA0d6e973c-1344-4350-9e76-1a56fd4f9e7e |
microRNA0d6e973c-1344-4350-9e76-1a56fd4f9e7e |
molecular diagnosticsa2f406b3-8d0b-426b-aeee-3b0822313669 |
mRNA vaccines3f3fe7d7-4776-4755-ab8f-6bfee1df53d1 |
mutant clones0d920f63-13fc-4fac-8715-1dfcc9e0bbe2 |
Nanoparticle Tracking Analysisf513ad63-0841-49d2-ac0a-74b5222a0f41 |
necroptosis923c926d-99b6-4b20-82f3-c43fca5a71f9 |
network inferencef5841ca1-8230-4144-b3e6-24b4c853584d |
NF-kBbd84c7c7-2a89-4ef5-aba5-3c7c30e8ace7 |
palliative care7d29982c-790b-48a9-8e4f-d8edf2a52243 |
patient participationd8777bb5-9b41-45c2-88db-3595c3ca035b |
peritoneal metastasisab810780-75e2-4200-ae1a-c94d1797b20b |
Personalized cancer therapybda16243-4cd6-4761-b89e-8447c373a2c6 |
posttranslational modificationsf4dd6811-2b26-4436-9729-b6ce77e8370b |
Precision medicine102ee14f-47f4-4c73-b12b-4cda550e8155 |
public health2f055824-349e-4c91-a171-d2792a7a8fd6 |
soft tissue sarcoma76f3c4bd-8a98-426e-9d43-e38884fa6369 |
stem cellsfcd2359f-ec29-490e-b46e-1b43b0b689d2 |
testicular cancer102ee14f-47f4-4c73-b12b-4cda550e8155 |
therapy response predictiona2f406b3-8d0b-426b-aeee-3b0822313669 |
trace elements87a47972-f22d-4e1a-bd75-4cbb405b6667 |
Transgenic Mouse models36d0349c-3368-4d46-a166-ccfca4d342fc |
tumor evolution0d920f63-13fc-4fac-8715-1dfcc9e0bbe2 |
Tumor heterogeneitybda16243-4cd6-4761-b89e-8447c373a2c6 |
tumor-associated macrophages574effad-4de9-47f0-9f03-1698ad225950 |
Xenopusc0c4f96a-86f7-48f5-b65d-1501aa6719af |
Biofluids0e0c7241-8a31-4bc5-b8e0-a3fc1e948f3d |
biopharmaceuticals664a932f-fca0-4131-a6c0-561bb9c4e3ef |
bioprinting341a7c8c-2104-4f8a-8fec-8423a4d1c301 |
blood-based biomarkersd39a8132-73fd-4396-b8d1-43930ff573c6 |
Cancer modelse556a821-a7fe-4bd0-a9de-96ae7dd7e283 |
circulating tumor cellsf5841ca1-8230-4144-b3e6-24b4c853584d |
computational deconvolution292b1e7f-8d47-4d6c-8e58-9a91d36f80bd |
copy number data69470811-eb43-48dd-aad6-bda5e968194c |
cytokine therapyd5679322-c470-4903-9c0c-f5ec7c5ab2ac |
DAMPs8c79b65e-110d-4ff6-a877-28eb00f15311 |
doctoral schools713a73fc-fe18-4aef-b62a-d7e6d44f961a |
early phase clinical trialsbcedba3c-bea0-4543-8d9d-22274d068ee2 |
Electron microscopy102ee14f-47f4-4c73-b12b-4cda550e8155 |
fluorescence microscpoy89edd557-2ac6-44fe-8ad3-171cf78b0255 |
gastric cancer80d74a39-d94b-4bda-a979-bc7d4fffde79 |
hepatocellular carcinogenesisd39a8132-73fd-4396-b8d1-43930ff573c6 |
histones4dcc7156-f499-4ea7-9bb0-42f1caac44c0 |
Histopathology102ee14f-47f4-4c73-b12b-4cda550e8155 |
hypoxiad312dc3e-593c-4c21-9307-2bfd5beca822 |
Immunohistochemistry102ee14f-47f4-4c73-b12b-4cda550e8155 |
Kinetics6ec9a11f-76ab-4326-aa4c-172891022a17 |
light microscopy89edd557-2ac6-44fe-8ad3-171cf78b0255 |
metabolisma487ed86-3872-4887-9bf0-9b606359f466 |
microbubblesab9886dd-2896-4797-befb-13d7fe84a4d2 |
molecular signaling9411a205-dffe-4cc9-9cce-5354d50e9845 |
mRNA therapeuticsfe814a84-8099-4003-ab82-211f8975fa22 |
mutational signatures0d920f63-13fc-4fac-8715-1dfcc9e0bbe2 |
nanodelivery6351d995-f631-477b-95c4-082338751c00 |
networks00150295-523e-4e2a-8e6e-3036a5987de5 |
neurosurgery8021d494-9112-45b8-9e3f-05581f7a217f |
NSG in vivo model7d490880-f428-44b9-8bdb-c3106f53171a |
omics data00150295-523e-4e2a-8e6e-3036a5987de5 |
partial nephrectomy46d542dd-a048-45be-b3c0-947d693225aa |
pathologyecf47376-ba0c-4c47-8520-c00c0f0e2a57 |
pharmacogenomicsfeb4c460-39e7-4fdd-90d7-bf429c808cb4 |
Phase Icb4e49a1-4797-4efc-bb21-4c9ef833ddf2 |
PIPAC581811ab-d986-4928-b7eb-619b00e6ec27 |
PROTACaeb71553-6f43-40bc-824b-7d58e16454c8 |
protein complexes871ab459-ce5b-4263-8996-67e59314dea3 |
psychology5ef08917-ce52-4433-bc14-9c82a51fde8a |
radiopharmacy7438f30f-f58c-49cd-8410-254442984b74 |
radiosensitivity06092b29-82db-49e9-9a17-cccc295dcbd7 |
replicative stressf3ab7110-cd3f-4cd6-aef4-c19afd11979d |
RRBSb3dfb72b-c367-4594-bd3a-297c22bae435 |
small-molecule drugs8d8632bd-51a5-42b5-ae1f-ecb919cf031d |
social inequalitiesaa46a927-0144-454e-b5a5-beef50d4769e |
spatial biology581f372a-8da8-4df8-9517-7a5454dc35cc |
statistics1cd4c65d-2cea-42b1-9fa2-b4400389b660 |
supportive care84a3f996-157d-4448-966b-959e64534ce5 |
T cell differentiation4aad48e7-5d26-472f-b168-d05750489868 |
therapy efficacy133a010a-8fc2-43fd-afc6-3b6bff86424a |
Tumor metabolismbda16243-4cd6-4761-b89e-8447c373a2c6 |
tyrosine kinase inhibitorscab3d630-f9e8-4fed-9538-2179d1c32256 |
ubiquitination2f7048b6-69b9-4a86-ae3c-6466056615a2 |
urology66b45939-48e4-478b-97f4-4216326b839d |
xenograft739f0456-34fe-4716-8f67-42a0be2e1038 |
ZEB1/2049ebbd6-c25d-4c52-b47f-8c93ebe3852a |
zebrafishf1a761da-3432-4140-a738-20481604b570 |
activity-based costing25ac1c5d-63fe-4048-a288-468df4d5b49d |
animal models95848056-0534-443f-bca8-93a2e14b7223 |
bio-imaging87a47972-f22d-4e1a-bd75-4cbb405b6667 |
bone tumorb422944c-3f7b-4fba-b893-b05bcf6f80c9 |
Cancer assiosiated fibroblastc0a44e86-dfa4-4b80-b810-7a9ab424cbce |
cancer therapyb486896d-fb50-42c9-b223-833e050465f8 |
Carcinoma102ee14f-47f4-4c73-b12b-4cda550e8155 |
cat76b81b50-91d7-4bfa-b91f-709ec7b52f75 |
circulating RNA biomarkers6cc04bde-72ca-480f-9586-22e3f3f69033 |
colitis12f62667-46d4-487c-a7c9-b326d23cbc9a |
combination therapyf8a2f1c3-91d1-458b-ae6b-28559e63cc3f |
comparative oncology0594bed9-8ce1-4d5e-bfc9-806c18c1f29e |
computational fluid dynamicsdb100c91-781b-4b3f-bae8-fb35c8023ef2 |
core facilityaaa64161-6c77-4a1b-bd08-830eb75512ef |
crosslinkf134030f-edf7-4f15-b102-5820c454f301 |
CTf33bfdec-eac8-4de1-8572-72eea327dc24 |
cyclic lipopeptides81acb838-0db4-4fe3-9bb1-5c467907cdad |
Data Mining0fc3e09a-f7c8-4b3e-90a7-851012155678 |
deep learningec2ec12c-eead-4649-9c1a-97b9d9174548 |
diffuse large B cell lymphoma2f7048b6-69b9-4a86-ae3c-6466056615a2 |
digestion metabolitesd55b9ab4-6ced-4f3c-8f0c-06838fcc285f |
digital PCR0d6e973c-1344-4350-9e76-1a56fd4f9e7e |
DNA repair mechanism06092b29-82db-49e9-9a17-cccc295dcbd7 |
dog76b81b50-91d7-4bfa-b91f-709ec7b52f75 |
dPCR1cd4c65d-2cea-42b1-9fa2-b4400389b660 |
Drug development933a9896-64ce-4244-87db-70ba849f466b |
early detectionbeffe4a6-6d92-4262-a79f-3cc38c647cd7 |
embryonic stem cells68c2ae11-89e8-4ef5-a4ae-544095a9978a |
end-of-life care7d29982c-790b-48a9-8e4f-d8edf2a52243 |
environmental pollutantsc2a0faa8-3d1d-4f87-a90e-50ee4be1237e |
ethnic inequalities682d41a7-f773-4acf-90ea-f44942623fc8 |
FFPE samples8386dfe1-bbf1-4b9a-8186-c3b8cc3914a3 |
FISH102ee14f-47f4-4c73-b12b-4cda550e8155 |
fluorescence6a59985f-8999-431c-ac89-e0620d9bddc9 |
food9fe49be8-2095-48cb-b92e-ae8b6515518c |
food safety2f055824-349e-4c91-a171-d2792a7a8fd6 |
furan4a078560-fb27-4c2e-a0b6-0d82f945f97e |
G-quadruplexc7ed0249-7e1a-41a7-bdbd-c8088aec7250 |
Gastro-intestinal50c181b6-24d2-48a1-ba17-60ed441f78e2 |
gene editing096e89c0-afd6-4ba7-81fd-edd6e7ef7b03 |
genome engineering26294723-5a9e-47c9-99d5-d89bb08904b9 |
glioblastoma6d1d6630-bc44-400b-9b88-a14ce9bed562 |
hard-to-reach populationsa78261ce-e0b7-4e1d-9410-53bbb6f9f587 |
healt economicsba7db225-980c-4bf4-bb8c-9e93cc57f7bf |
homologous recombinationa799fb18-b5b0-444d-b04e-6e102f1ff001 |
hypofractionationadf985df-d11d-4704-946c-7ccc898f5e6d |
immunotherapy5b97c928-0e0b-49e0-a1c0-a9c6092b6c4a |
in vitro model9fe49be8-2095-48cb-b92e-ae8b6515518c |
in vivo optical imagingd5679322-c470-4903-9c0c-f5ec7c5ab2ac |
Interactomics687460a6-6b8c-4542-8890-5b37c364ca8f |
interprofessional cancer care0416a498-8e41-4f35-91b4-ac91819d3fb7 |
Invasion9c357f9e-74b4-4376-8dbb-69e9be836e57 |
isotopic composition87a47972-f22d-4e1a-bd75-4cbb405b6667 |
Kankercongres8d0a957e-adad-4ef9-8c4a-33ce73cb7cad |
Kankercongres8d0a957e-adad-4ef9-8c4a-33ce73cb7cad |
kidney perfusion46d542dd-a048-45be-b3c0-947d693225aa |
Kom op tegen Kankerfd598e1c-be42-43d8-8302-3fcf38f7ba24 |
Kom op tegen Kankerfd598e1c-be42-43d8-8302-3fcf38f7ba24 |
Lipidomics0e0c7241-8a31-4bc5-b8e0-a3fc1e948f3d |
liposomesab9886dd-2896-4797-befb-13d7fe84a4d2 |
mast cell tumord790d311-5c55-4ace-aea8-bd438d63c3e5 |
mesotheliomae675ca6f-2e02-469a-91e5-2830a7f4f21f |
modelling and simulationfd7f596b-a5e5-44f0-a18b-fbe7c6a2959b |
Multiplex30520d4c-9ba6-4d94-88a0-242ec3da47ac |
N-glycanf57fb4d5-f2d9-4ab0-8f65-4e3f916e1691 |
neuroblastomaa1f34b67-c57f-4160-995e-e90996767d22 |
neurology8a6025ee-7b79-40f8-a5a9-7ec991a1b792 |
Oncologisch Centrum012cdf7a-7705-4f84-abcd-5196249333da |
Oncolunch417f3196-064d-4068-9b5e-32244125dadb |
Organic chemistryb3ece6b3-6c84-4294-8f67-9afbe9441891 |
palliative sedation7d29982c-790b-48a9-8e4f-d8edf2a52243 |
patient-specific surgery46d542dd-a048-45be-b3c0-947d693225aa |
peptides discovery5c5d8dac-b00a-4849-a365-8ada3335fac3 |
photodynamic therapy5790b7b7-e5e7-4f80-a7a2-1a00eb586bcd |
point-of-care tests5641ed5a-3fde-4ba7-ac47-03335bccdfdc |
pressurized intraperitoneal aerosol chemotherapy387ced05-cf0e-430f-9e97-6289d5b419f2 |
prostatectomyaadf8a6f-27ad-4d1b-8fe4-5b8830b79634 |
protein purificationd47ac4fc-530f-4758-b445-b5a49742c812 |
proton therapy158f5720-02af-4c9c-844e-630e449bf1fb |
PSMAdf53d89e-6900-4f3b-be67-f13884c4cc61 |
radionuclide therapy9129a8f9-f60d-4c24-8a2b-3d9a1c44efe5 |
regulatory networks7e1d6d23-c16f-44c1-9770-2e73d28fca12 |
sarcoid12c18ad4-bc67-4c16-8f86-ddfb1bdeea7c |
SBRTbb4f2d72-2b0b-449d-a53e-622a2e736650 |
Self Amplifying mRNA570aba77-f649-438c-93d4-aaf3ff004b4f |
self-samplinga78261ce-e0b7-4e1d-9410-53bbb6f9f587 |
sequencing68c2ae11-89e8-4ef5-a4ae-544095a9978a |
SPECT3212fdca-296d-4222-b947-a682e829eb57 |
spontaneous cancer76b81b50-91d7-4bfa-b91f-709ec7b52f75 |
T cell therapy4f3d88e1-961d-4a72-b76e-6fda40aebb91 |
targeted drug deliverydb100c91-781b-4b3f-bae8-fb35c8023ef2 |
therapeutic monitoring17dfda7e-7720-4f7f-97dc-7f6635fe1e32 |
therapy response6d1d6630-bc44-400b-9b88-a14ce9bed562 |
tumor biobank9e24bb70-020b-473f-9221-22d3f04d1ba8 |
tumor classificationecf47376-ba0c-4c47-8520-c00c0f0e2a57 |
urinary biomarkersd39a8132-73fd-4396-b8d1-43930ff573c6 |
Wilms tumor6f36d0e4-b9f9-4168-b7fe-aa0abcece180 |
ZEB1161c5428-7a29-4dc0-ad59-58ca15558ce2 |
4C-seq9c43fa2f-c21c-4149-9da0-a5413bb04b5b |
A20d54bbd51-ea52-4aa2-b66b-26c8c55f5830 |
academic clinical trialsbcedba3c-bea0-4543-8d9d-22274d068ee2 |
access to care25ac1c5d-63fe-4048-a288-468df4d5b49d |
AcTakineaa7da943-090f-4bcc-b150-57d3b93ee7f1 |
actin cytoskeletondbe22699-238b-46d5-91c4-8d916c5882a1 |
adolescent and young adult8191bbd1-83df-48eb-9de0-bdac7aa273b8 |
ALK0d920f63-13fc-4fac-8715-1dfcc9e0bbe2 |
allergy2f059b66-44c4-4abd-9fb1-2137a8900d7e |
aptamerse548a3dd-bab4-45bd-ad99-5e1ed1d4cde3 |
assays59b8de0e-fbf2-4f8b-80c4-d661e4fd8877 |
autophagyd54bbd51-ea52-4aa2-b66b-26c8c55f5830 |
AYA8191bbd1-83df-48eb-9de0-bdac7aa273b8 |
BACR1cf21ef2-ce2c-4f3e-8834-13b38d1594a2 |
Bacteria50c181b6-24d2-48a1-ba17-60ed441f78e2 |
bioconjugation7a1de9e9-e4ca-49ca-8aba-12504a27fa9f |
biodistributionde88e604-babd-4d99-92c1-3240583feabb |
biologicsfb11dd20-e25d-4653-bfb6-7c56d0845d7d |
biomarkersbd9dbe48-a6b5-4907-982a-f853a49fc19b |
biomimetics8fda57b9-0387-415d-8497-d5cfbaedce78 |
biomolecular interactions2ae76a31-1840-4b37-8b77-1549567d3f16 |
bisulfite sequencingecf47376-ba0c-4c47-8520-c00c0f0e2a57 |
BiTE4f3d78df-c7e5-47c3-a3c3-e38e711eabea |
BPV12c18ad4-bc67-4c16-8f86-ddfb1bdeea7c |
breath hold479eb599-4aed-49b7-8764-9f23728ced2c |
cachexia5ef7a3e7-c911-44b0-9f77-33a1dfb33b9c |
CAF9117d571-5159-4ed2-a457-b4d998085bc7 |
cancer immunotherapy1ce6fa23-4416-457f-9b52-f1f4f6c010ab |
cancer invasiondbe22699-238b-46d5-91c4-8d916c5882a1 |
cancer of unknown primaryecf47376-ba0c-4c47-8520-c00c0f0e2a57 |
care pathway02d04219-eded-417c-a039-b53bd9afc670 |
caregivers66898326-daf8-480f-b97a-1e4873129622 |
cell death mechanisms93fc082c-19d0-4a6c-a887-59277569cd13 |
cell sorting4dbd3521-8c17-44ca-9588-d5fc4de5e234 |
cell-based59b8de0e-fbf2-4f8b-80c4-d661e4fd8877 |
cfRNA2b9a0419-762c-4fca-8685-b5fd74c1620e |
chimeric antigen receptor3c1741ce-8092-4e5d-b762-c221963afc25 |
ChIP-seq9c43fa2f-c21c-4149-9da0-a5413bb04b5b |
chronic myeloid leukemiabcedba3c-bea0-4543-8d9d-22274d068ee2 |
circular RNA0d6e973c-1344-4350-9e76-1a56fd4f9e7e |
click reactions4a078560-fb27-4c2e-a0b6-0d82f945f97e |
Clinical research9e24bb70-020b-473f-9221-22d3f04d1ba8 |
clinical tissueaaa64161-6c77-4a1b-bd08-830eb75512ef |
clinical trial centerd3f8a22e-500c-41d3-a547-66a4eb33f2c6 |
clinical trialsbde2d1e0-9b32-4ba8-bab1-976e721039a5 |
CLIPs81acb838-0db4-4fe3-9bb1-5c467907cdad |
compound screeningebd77b40-4fc0-4b6d-a58a-83f42fe76020 |
compounds59b8de0e-fbf2-4f8b-80c4-d661e4fd8877 |
computer modellingdb100c91-781b-4b3f-bae8-fb35c8023ef2 |
computer vision46d542dd-a048-45be-b3c0-947d693225aa |
confocal microscopyb7a49f6a-bcf1-48d9-8a21-9ba4e88e837b |
conjugate synthesis8f91360c-3d0b-484a-ac47-833f388880c5 |
controlled drug released037c813-b813-4682-a07f-9528a9c6480b |
crispr0c349a67-fcd4-4b75-acac-ddc2f809fe48 |
crystallography7d0b0e8d-0de8-46a9-a5ea-9cb761ada461 |
CTCs7484abc2-4697-4ba3-87d0-4c8c00a697d7 |
CUPecf47376-ba0c-4c47-8520-c00c0f0e2a57 |
custom nanobody66f0dd28-079e-4456-b6e0-0226650b50b2 |
data integration00150295-523e-4e2a-8e6e-3036a5987de5 |
data sharingd6406e85-6bac-4dd8-bb70-7316a0702599 |
dermatologyd19fe1cd-063c-4571-aa0a-894412128c42 |
DNA fragmentation5bd220fb-7f98-44c6-a023-6c56edbbac52 |
dose calculation6152dfcb-4bac-425e-b630-a39ac8ebf2bc |
drug response1141abc4-1cd0-4163-8675-7264f27b2260 |
Drug Transport4b478354-3527-448c-b40f-c472001e4fbd |
educatione49a8b86-c80b-4179-ac2e-e37bfcc4a703 |
elderly3f7b0a0f-1123-4adf-9d18-8f958ecbac82 |
end-of-life decisions7d29982c-790b-48a9-8e4f-d8edf2a52243 |
endocrine tumorsb1e4fee9-9829-4651-bee1-cdeae1f5b59c |
epitranscriptomicsb6d47135-2920-474a-97ca-035988e8e9ed |
equity in health caree086a0d3-5760-4e8e-b471-a613a169c4b1 |
ER Stresscbd9d6f1-56da-4a1a-a801-1ee71eff4ea4 |
esophageal adenocarcinoma0d6e973c-1344-4350-9e76-1a56fd4f9e7e |
exercise science84a3f996-157d-4448-966b-959e64534ce5 |
extracellular RNA2b9a0419-762c-4fca-8685-b5fd74c1620e |
familial cancerf3bf3a2f-0448-44b4-b9ec-7011979b1ee1 |
family66898326-daf8-480f-b97a-1e4873129622 |
fibrosis5bf37f7f-f9f6-4310-b17c-e49620ac515d |
FLIMa8f9a76c-a3bf-4829-9797-22fd00f14a96 |
Fluorescence Lifetime Imaging Microscopya8f9a76c-a3bf-4829-9797-22fd00f14a96 |
Fluorescence-in-situ hybridization102ee14f-47f4-4c73-b12b-4cda550e8155 |
functional assaysa799fb18-b5b0-444d-b04e-6e102f1ff001 |
Gastrointestinal80d74a39-d94b-4bda-a979-bc7d4fffde79 |
genetic testing1e2531fe-783a-4f5d-9671-ab3a397b5861 |
glycan analyticsd47ac4fc-530f-4758-b445-b5a49742c812 |
glycolipid antigens63cd1123-96c1-46c3-93a2-ed7d7a86663e |
Healthy Volunteers8b21b748-d4cc-478f-8f27-c31262cc815e |
HIRUZ9e24bb70-020b-473f-9221-22d3f04d1ba8 |
horse12c18ad4-bc67-4c16-8f86-ddfb1bdeea7c |
HPV5641ed5a-3fde-4ba7-ac47-03335bccdfdc |
human biomonitoring9b0e8de2-f3fe-4267-ba90-6c624d702dbe |
hyperthermia882a5d96-bfaf-4222-a9ad-6742da1fcb4d |
immunomonitoring40966da4-5fb3-43ad-98d1-4e2d8f5c7def |
immunophenotypingb95bbf2a-1e6d-4244-8526-a3491e816e8c |
immunosuppressiond5679322-c470-4903-9c0c-f5ec7c5ab2ac |
in vitro T cell generation7d490880-f428-44b9-8bdb-c3106f53171a |
innate immunityae5d7248-1185-434a-86ed-525f7f40b20a |
innovationf0e8d4ef-578b-4225-a609-3b163406411a |
intellectual property26fd97d7-6e03-4c85-a3db-59458431e5ca |
interstitial fluid pressured0ac3830-9829-401a-86cf-bb8cabdfab4e |
light-sheet microscopy43ed4cc1-2c86-46cc-b899-aa396fe795d1 |
lipid nanoparticles862e35a8-f290-4198-b62d-09a4560e7cea |
liquid biopsiesae02d6f6-9f8a-4b90-a59c-a5faaa349a8c |
live-cell imaging6a59985f-8999-431c-ac89-e0620d9bddc9 |
long read sequencing72789ed0-8d99-4c55-a148-b18f8cc0f2d6 |
luminescence6ec9a11f-76ab-4326-aa4c-172891022a17 |
MACSima581f372a-8da8-4df8-9517-7a5454dc35cc |
MALT12f7048b6-69b9-4a86-ae3c-6466056615a2 |
microarraysb8aba570-3296-4483-a4ec-6f800c336010 |
micronucleus assay31a02354-6dda-4b5a-9dad-b9425e033956 |
Mineralocorticoid receptorbd84c7c7-2a89-4ef5-aba5-3c7c30e8ace7 |
molecular dynamics8f3d9da6-894f-4d8e-9d8f-0da1eae1f791 |
molecular modeling4b478354-3527-448c-b40f-c472001e4fbd |
motility trapping8021d494-9112-45b8-9e3f-05581f7a217f |
myelodysplastic syndromec973f964-44f1-42f6-be3b-6dda045c3394 |
myeloid cellse8790cf4-1ad4-4bd0-805f-118723bb2c38 |
myeloid-derived suppressor cellsb95bbf2a-1e6d-4244-8526-a3491e816e8c |
network modelling28a0aba3-ed4f-41be-bc10-ca589d3ad165 |
neuro-cognitive functioning3f7b0a0f-1123-4adf-9d18-8f958ecbac82 |
NGS98a0cf33-3363-4c1d-a27c-d627ece9e964 |
NK celld0acc655-4965-4b5f-9f15-f020892cf741 |
Non-alcoholic fatty liver disease4882fe70-aba0-4ed8-9752-09766d586956 |
non-viral gene therapyde88e604-babd-4d99-92c1-3240583feabb |
nuclear receptor crosstalk3ecbcdb1-5a94-489d-bc19-a3ee2e77fca0 |
nursing0416a498-8e41-4f35-91b4-ac91819d3fb7 |
nutrigenomicsc6f428e9-9d8d-4bc4-ac47-678d9ca56db1 |
Oligometastasesbb4f2d72-2b0b-449d-a53e-622a2e736650 |
oligonucleotidesc7ed0249-7e1a-41a7-bdbd-c8088aec7250 |
Oncological center012cdf7a-7705-4f84-abcd-5196249333da |
Oncological center012cdf7a-7705-4f84-abcd-5196249333da |
Oncologisch Centrum012cdf7a-7705-4f84-abcd-5196249333da |
out-licensing26fd97d7-6e03-4c85-a3db-59458431e5ca |
pathway activity scoresf5841ca1-8230-4144-b3e6-24b4c853584d |
patient experienceaad25fad-330a-4f3f-9743-1c74741b62e8 |
patient reported outcomes25ac1c5d-63fe-4048-a288-468df4d5b49d |
pediatric clinical trials133a010a-8fc2-43fd-afc6-3b6bff86424a |
pediatric leukemiabcedba3c-bea0-4543-8d9d-22274d068ee2 |
pediatric sarcomaf8a2f1c3-91d1-458b-ae6b-28559e63cc3f |
PET-CT71c3f51f-4ea6-4836-9272-8d0042640046 |
pharmacokinetics5c5d8dac-b00a-4849-a365-8ada3335fac3 |
phenotypic59b8de0e-fbf2-4f8b-80c4-d661e4fd8877 |
phenotyping2ec595cb-b42d-4333-859a-5ad15a0f6189 |
photo-electrochemistry702b0ea8-78cf-44f5-b4dc-ab1a3d7678fc |
physical activity11c862b6-f187-4f2c-9f63-26348de984d7 |
Pichia pastoris0d732be0-4cac-4fb3-b8f0-1ebea7adcbcf |
plasma biomarker5c97384b-9895-4925-85ee-f40efe37ff48 |
polymer therapeutic7f9a454c-0109-4b6c-9e61-0c932ce292b6 |
predictionc0a44e86-dfa4-4b80-b810-7a9ab424cbce |
predictive modelsadf985df-d11d-4704-946c-7ccc898f5e6d |
preoperative planning46d542dd-a048-45be-b3c0-947d693225aa |
primary immune deficiency disease9a57f718-93dc-415b-acd1-0d13507af4fa |
prone radiotherapyd5deac7b-d853-4ec9-b1c3-6a3fd69be05a |
protein identification4dcc7156-f499-4ea7-9bb0-42f1caac44c0 |
protein modification3fe7c213-6bd7-4d9a-ad16-5fd8b5280afd |
protein quantification4dcc7156-f499-4ea7-9bb0-42f1caac44c0 |
protein-ligand binding8f3d9da6-894f-4d8e-9d8f-0da1eae1f791 |
Protein-protein interaction445c4803-bb8f-4675-b55b-1bc4ce009a57 |
psychosociaal oncologisch team5ef08917-ce52-4433-bc14-9c82a51fde8a |
pyroptosisbe7d37b1-9437-43fa-aa29-7df738b7067e |
radiation exposure31a02354-6dda-4b5a-9dad-b9425e033956 |
radiation-induced DNA damage06092b29-82db-49e9-9a17-cccc295dcbd7 |
radiation-induced toxicity5fa50a5f-a39b-42bf-b28f-21ad82432acb |
rare cell isolation7484abc2-4697-4ba3-87d0-4c8c00a697d7 |
rat modelsa3543560-f4b9-420f-8558-df850e27f4c1 |
rectal cancer4b774cfd-cfc0-4d3c-9c9e-9e0e604b7ab4 |
recurrence riskac2136c2-4708-4234-8943-da1e20bec480 |
red meatd55b9ab4-6ced-4f3c-8f0c-06838fcc285f |
regulatory affairs5c5d8dac-b00a-4849-a365-8ada3335fac3 |
renal cell carcinogenesis099bfd75-028d-42c5-82f4-4ebac498611e |
ribo-seq72789ed0-8d99-4c55-a148-b18f8cc0f2d6 |
RNA therapeuticsa270f039-d70c-4ab1-84f0-25181f9a33e1 |
robotic surgery03927438-49a0-47e9-b23c-69327136fe22 |
scaffolds0f9554d4-8513-4a55-be10-ef94ef228f9e |
self-management84a3f996-157d-4448-966b-959e64534ce5 |
single cell proteomicsa668496b-6caa-4b4e-8dfe-d43a9ae16414 |
singlet oxygen702b0ea8-78cf-44f5-b4dc-ab1a3d7678fc |
siRNA screening161c5428-7a29-4dc0-ad59-58ca15558ce2 |
skin cancer model786e5d77-454d-440c-925c-939e94d095f8 |
spatial genomics0d920f63-13fc-4fac-8715-1dfcc9e0bbe2 |
spatial omicsc1013a24-a9e8-477c-a617-635bba4ee3dd |
STED microscopyb7a49f6a-bcf1-48d9-8a21-9ba4e88e837b |
stem cell transplantationb4459e1b-67af-4d12-83b9-4c37315c7ddf |
Super-Resolution Microscopyb7a49f6a-bcf1-48d9-8a21-9ba4e88e837b |
synthesiscf8ccdd1-e0c7-4961-be02-d58aa9d646a5 |
T cell immunotherapye1414a32-f92b-4698-8ebc-dfc837244ef1 |
technology & business development26fd97d7-6e03-4c85-a3db-59458431e5ca |
time lapse microscopydbe22699-238b-46d5-91c4-8d916c5882a1 |
tumor-infiltrating lymphocytes739f0456-34fe-4716-8f67-42a0be2e1038 |
unfolded protein responsecc92d7a7-5103-4741-8774-dd8b9ef28780 |
vaccinationb28caba7-a119-4594-ab28-080a20b68a59 |
vaccined312dc3e-593c-4c21-9307-2bfd5beca822 |
WGS8386dfe1-bbf1-4b9a-8186-c3b8cc3914a3 |
Wnt signaling19e1e2da-0f1f-4e9a-9d82-25a1bbd6215a |
wound healingbe7d37b1-9437-43fa-aa29-7df738b7067e |
yeast0d732be0-4cac-4fb3-b8f0-1ebea7adcbcf |
'Nature-inspired' drug development933a9896-64ce-4244-87db-70ba849f466b |
3Dab810780-75e2-4200-ae1a-c94d1797b20b |
3D imagingb7a49f6a-bcf1-48d9-8a21-9ba4e88e837b |
3D migrationdbe22699-238b-46d5-91c4-8d916c5882a1 |
abdominal surgery4b774cfd-cfc0-4d3c-9c9e-9e0e604b7ab4 |
accelerated radiotherapyadf985df-d11d-4704-946c-7ccc898f5e6d |
Acceptance and Commitment Therapy66898326-daf8-480f-b97a-1e4873129622 |
AcTaferonaa7da943-090f-4bcc-b150-57d3b93ee7f1 |
AcTaferonaa7da943-090f-4bcc-b150-57d3b93ee7f1 |
AcTakineaa7da943-090f-4bcc-b150-57d3b93ee7f1 |
adaptive radiotherapyff5ee05a-14df-47e7-a840-c012229642ff |
ADC39724297-ae46-4293-8850-47b9b3049d3d |
adherence0416a498-8e41-4f35-91b4-ac91819d3fb7 |
Adhesionc1251d10-4998-4dd6-b441-2cb20cf33040 |
adipose tissue8fda57b9-0387-415d-8497-d5cfbaedce78 |
adjuvantsfe814a84-8099-4003-ab82-211f8975fa22 |
advanced care planning321f6001-6d12-4990-af65-758745442c4f |
ageing3f7b0a0f-1123-4adf-9d18-8f958ecbac82 |
alpha-tubulinbe751e27-d43d-4b44-bd57-11de4408586c |
amyloidosis1e2102dc-6967-4904-9b85-e26fe86ce86f |
anal cancer80d74a39-d94b-4bda-a979-bc7d4fffde79 |
analytics7dc8b10a-0477-40b9-8f77-f33f21bbd592 |
androgen deprivation therapy1ff04bcb-a7b8-43fc-bab4-5e5241ca602d |
angiosarcoma2ab1fb59-09b2-48dc-a836-9e82e64eeb9e |
annual report9afbf231-64ca-4ca9-8614-da6ce340beed |
annual report9afbf231-64ca-4ca9-8614-da6ce340beed |
anti-metastatic compounds5e92195b-a716-45a9-a3aa-36cde89a6e91 |
antibody recruitment7a1de9e9-e4ca-49ca-8aba-12504a27fa9f |
antibody-drug conjugates39724297-ae46-4293-8850-47b9b3049d3d |
anticancer treatmenta96857bf-6919-4d20-a1ee-890de7ab7204 |
antigen0d732be0-4cac-4fb3-b8f0-1ebea7adcbcf |
antigen presentationa4699f5b-9ea6-4e75-bf4a-582a80db41a3 |
antimicrobial peptides81acb838-0db4-4fe3-9bb1-5c467907cdad |
antisense technology0d6e973c-1344-4350-9e76-1a56fd4f9e7e |
asthma2f059b66-44c4-4abd-9fb1-2137a8900d7e |
ATAC-sequencing4e1c6948-fa44-4f2d-9da5-72db1356c2b6 |
atypical pleomorphic lipomatous tumorac93331c-6132-4862-a64d-76a97dd77bb0 |
AuNPs01de78c1-051b-4510-b4ce-e71de6dfc5ad |
automation59b8de0e-fbf2-4f8b-80c4-d661e4fd8877 |
B cell lymphoma85bdda86-f13e-45e4-bf50-30266abec561 |
BCCM-LMBP88fcd385-0156-4be4-af18-294db0f6dda7 |
bibliotherapy32678b2d-dd90-461b-aefe-3e8ea7beb7d9 |
Binding-affinity035df82b-8bd8-4ae6-955b-1e1d98559bb9 |
bioavailability9fe49be8-2095-48cb-b92e-ae8b6515518c |
Biobank initiatives9e24bb70-020b-473f-9221-22d3f04d1ba8 |
biodosimetry31a02354-6dda-4b5a-9dad-b9425e033956 |
bioimmunoengineering664a932f-fca0-4131-a6c0-561bb9c4e3ef |
bioluminescence70b1724a-cc0c-46c0-b8e2-4d718c98ace7 |
biophotonics923d8a39-b8d0-472a-b14b-e7e8763bfe4d |
biostatistics2f1e91d3-7761-4c24-8325-39af1d9d9919 |
blebbistatin5e92195b-a716-45a9-a3aa-36cde89a6e91 |
body-fluidsf3d5b128-1e65-4667-94ed-6b5e2a77f05f |
bone sarcoma76f3c4bd-8a98-426e-9d43-e38884fa6369 |
brain cancer6d1d6630-bc44-400b-9b88-a14ce9bed562 |
BRCA21ff635af-c5a5-48f3-b3ce-b5e45a257601 |
breast reconstruction4ba34853-c350-4435-a2d5-82c33521df8f |
breathomicsd312dc3e-593c-4c21-9307-2bfd5beca822 |
BSPHO133a010a-8fc2-43fd-afc6-3b6bff86424a |
Burkitt lymphomad1eb9cf0-1124-4073-9e39-a924d6c43b31 |
business development26fd97d7-6e03-4c85-a3db-59458431e5ca |
Busulfancab3d630-f9e8-4fed-9538-2179d1c32256 |
CAD-CAMb6450923-4682-4ef4-bcad-f72678bf799c |
cadherinsc1251d10-4998-4dd6-b441-2cb20cf33040 |
cancer disparitiesaa46a927-0144-454e-b5a5-beef50d4769e |
cancer metabolism7d0b0e8d-0de8-46a9-a5ea-9cb761ada461 |
cancer survivorshipac005421-5655-4c9d-ae66-7a91379d451c |
cancer type specificity38166c15-a34f-42d2-8fb8-603fcbb079f1 |
capillary electrophoresis7dc8b10a-0477-40b9-8f77-f33f21bbd592 |
capsules5790b7b7-e5e7-4f80-a7a2-1a00eb586bcd |
CAR M cellse8790cf4-1ad4-4bd0-805f-118723bb2c38 |
carcinomatosise675ca6f-2e02-469a-91e5-2830a7f4f21f |
carcinosarcoma8cc114c3-934b-4801-a525-bf0678a6a78e |
caree8898110-af14-4002-8866-be53e0d20fab |
cat model50951142-acdd-4541-bc58-79978f5f1f5a |
cDNA81bdab74-da7c-4aff-9e13-f3ec5883052e |
CE-LIF7dc8b10a-0477-40b9-8f77-f33f21bbd592 |
cell cultureaaa64161-6c77-4a1b-bd08-830eb75512ef |
cell invasionbe751e27-d43d-4b44-bd57-11de4408586c |
Cell line81bdab74-da7c-4aff-9e13-f3ec5883052e |
cell-cell communication608cba0f-7a31-4e21-a70a-05a03eb19869 |
CellMissydbe22699-238b-46d5-91c4-8d916c5882a1 |
Cellular bioenergeticse1f1eaa9-c89d-480e-a154-57781469d9f9 |
cellular respiration33ce5ac9-f4ec-4c9d-aa4d-f02140a4fc41 |
chemical synthesis81acb838-0db4-4fe3-9bb1-5c467907cdad |
chemistry toolsb3ece6b3-6c84-4294-8f67-9afbe9441891 |
chemoattractant8021d494-9112-45b8-9e3f-05581f7a217f |
chemoembolizationdb100c91-781b-4b3f-bae8-fb35c8023ef2 |
ChemTechb3ece6b3-6c84-4294-8f67-9afbe9441891 |
cholangiocarcinoma80d74a39-d94b-4bda-a979-bc7d4fffde79 |
chronic immune activation20e9d772-4e30-43da-9a55-ef06ca22ccb3 |
chronic pain prevention1cdbc77c-209b-4e54-9854-4b9eb0bac367 |
chronic pain treatment1cdbc77c-209b-4e54-9854-4b9eb0bac367 |
cirrhosis25551bf1-8dcc-4473-876a-b7d1c6f27f75 |
CISHd24576e8-1c64-426f-aa8e-0c01d3059d25 |
Cisplatin469c1e46-752c-4689-989a-935aa3d2b59c |
CITE-seq608cba0f-7a31-4e21-a70a-05a03eb19869 |
CLIP-seqae5d7248-1185-434a-86ed-525f7f40b20a |
CLL85bdda86-f13e-45e4-bf50-30266abec561 |
clonality60656295-a71b-4357-a417-469e5e7aabbe |
coating5790b7b7-e5e7-4f80-a7a2-1a00eb586bcd |
cold air plasmaa8a58b8c-87af-43fd-a92d-0b47e6711cb8 |
colitis-associated cancere9c1eb94-c6b6-4951-9eab-a5aafabcd901 |
Commissie Oncology012cdf7a-7705-4f84-abcd-5196249333da |
Commissie Oncology012cdf7a-7705-4f84-abcd-5196249333da |
Commission Oncology012cdf7a-7705-4f84-abcd-5196249333da |
Commission Oncology012cdf7a-7705-4f84-abcd-5196249333da |
companion animals0594bed9-8ce1-4d5e-bfc9-806c18c1f29e |
computational cytometrye1414a32-f92b-4698-8ebc-dfc837244ef1 |
computational drug design8f3d9da6-894f-4d8e-9d8f-0da1eae1f791 |
computational modelinge1f5f24a-afaf-48ef-9d9e-187f5a405a45 |
computed tomography76bf3e5c-303c-4aaf-9944-a7c151348001 |
continuous flowcf8ccdd1-e0c7-4961-be02-d58aa9d646a5 |
contrast imagingab9886dd-2896-4797-befb-13d7fe84a4d2 |
coordinatora7a38c66-b5ad-4655-8c62-011cffb18ae7 |
cost-of-illness86969910-f3ff-436b-8a30-28048facc371 |
cost-utility86969910-f3ff-436b-8a30-28048facc371 |
covalent trapping40651768-b8a7-4869-857a-bad019c9cdf1 |
CRISPR screening0a0d0926-e826-4d35-8a48-f0133bb8e49c |
CRISPR-Casc0e802a2-b3bf-4d72-b0ba-0b2faef6c7a8 |
CRISPRid8eb9b72-1ed5-47f9-94af-ed4735d19b65 |
crystallopgraphy0d732be0-4cac-4fb3-b8f0-1ebea7adcbcf |
Culture collection81bdab74-da7c-4aff-9e13-f3ec5883052e |
curcuminoids666482d5-792d-4039-bd3f-4ef05c20384d |
cutaneous squamous cell carcinomaf2bdc476-698c-4674-ae9a-2a1e9b9e5a97 |
Cyclolipodepsipeptides4a078560-fb27-4c2e-a0b6-0d82f945f97e |
Cytokine30520d4c-9ba6-4d94-88a0-242ec3da47ac |
dasatinibcab3d630-f9e8-4fed-9538-2179d1c32256 |
Data Management9e24bb70-020b-473f-9221-22d3f04d1ba8 |
data protectiond6406e85-6bac-4dd8-bb70-7316a0702599 |
de novo lipogenesis7d0b0e8d-0de8-46a9-a5ea-9cb761ada461 |
decision-analytic models25ac1c5d-63fe-4048-a288-468df4d5b49d |
deep generative modelsd6406e85-6bac-4dd8-bb70-7316a0702599 |
deep mutational scanningac6a4052-367e-47c5-a1da-d203e5f9e404 |
deep neural networkd19fe1cd-063c-4571-aa0a-894412128c42 |
density gradientf513ad63-0841-49d2-ac0a-74b5222a0f41 |
Dermoscopy40966da4-5fb3-43ad-98d1-4e2d8f5c7def |
Desmoid tumorba009a65-9771-499b-876b-0fae82a458c2 |
development planningcdef93ab-9b0e-48ff-8b07-9b11d197ea4f |
dicentric assay31a02354-6dda-4b5a-9dad-b9425e033956 |
differential protein analysis4dcc7156-f499-4ea7-9bb0-42f1caac44c0 |
differentiation9c357f9e-74b4-4376-8dbb-69e9be836e57 |
diffusion9dd238b5-5e98-428a-a5cd-75d54c0570d3 |
distress7e0a5948-ad88-4f79-8e94-87f56d07fb1e |
DNA quantification3ca2bb5b-fb55-46ab-ad08-bda7edacdbab |
DNA therapeuticsa270f039-d70c-4ab1-84f0-25181f9a33e1 |
DNA-sequencer7dc8b10a-0477-40b9-8f77-f33f21bbd592 |
doctoral schools713a73fc-fe18-4aef-b62a-d7e6d44f961a |
dogsdf96fa38-7b0f-4190-b9a4-5fa31c8262b4 |
donations06ddc34f-29f9-41a2-b7be-a13374953ded |
donations06ddc34f-29f9-41a2-b7be-a13374953ded |
dosimetry6152dfcb-4bac-425e-b630-a39ac8ebf2bc |
driver identification2d93839c-9748-4a87-b79a-6c901a1f1f17 |
drug repurposing8a6025ee-7b79-40f8-a5a9-7ec991a1b792 |
drug response profiling3bd73f03-59c0-42c3-b846-40e24f8206e4 |
drug targets00150295-523e-4e2a-8e6e-3036a5987de5 |
DSA-FACE7dc8b10a-0477-40b9-8f77-f33f21bbd592 |
Dynamics4b478354-3527-448c-b40f-c472001e4fbd |
dysbiosis5641ed5a-3fde-4ba7-ac47-03335bccdfdc |
EBVd1eb9cf0-1124-4073-9e39-a924d6c43b31 |
economicsba7db225-980c-4bf4-bb8c-9e93cc57f7bf |
electromagnetic radiation32678b2d-dd90-461b-aefe-3e8ea7beb7d9 |
electroporationd5679322-c470-4903-9c0c-f5ec7c5ab2ac |
elemental mappingfb37aae6-0530-4b6e-9744-a7cf22e59ff9 |
endometrial cancer56a96793-4f75-4274-97f4-e9c7c1226ec4 |
endosomal escaped037c813-b813-4682-a07f-9528a9c6480b |
endosomesfb11dd20-e25d-4653-bfb6-7c56d0845d7d |
enzyme inhibitors7d0b0e8d-0de8-46a9-a5ea-9cb761ada461 |
epifluorescence microscopy7b0d84b5-a69d-4fb9-bbd2-05746246951c |
epilepsy8a6025ee-7b79-40f8-a5a9-7ec991a1b792 |
Epithelial ovarian cancere185bf8a-faaf-47fd-bc89-cbce08520d02 |
ethics321f6001-6d12-4990-af65-758745442c4f |
euthanasia7d29982c-790b-48a9-8e4f-d8edf2a52243 |
evidence-based needs assessment25ac1c5d-63fe-4048-a288-468df4d5b49d |
ex-vivo10fe778b-9626-4b52-84cf-4ed376677ca8 |
ex-vivo imaging1fcc3aa7-acd7-446f-8600-7e40b79e087a |
expression screen0c349a67-fcd4-4b75-acac-ddc2f809fe48 |
Extracellular matrixdbe22699-238b-46d5-91c4-8d916c5882a1 |
fatigue59c84621-6ec7-428b-8256-c973c31b395a |
FCSb7a49f6a-bcf1-48d9-8a21-9ba4e88e837b |
fibroproliferative disorderd4d4e077-1e28-496a-8aea-db69e02a9d30 |
fluorescence imaginge46240f3-bdb2-468e-bf00-92f53b82e7de |
fluorescence life timeb7a49f6a-bcf1-48d9-8a21-9ba4e88e837b |
fluorescence microscopy034467ce-4207-43fd-a77d-a994385009f3 |
fluorophore316d21f3-0524-429b-b1b4-227c59b6fe9e |
foci06092b29-82db-49e9-9a17-cccc295dcbd7 |
Formulationcac32cf4-940b-43c3-a814-9ac6ce3ebb9b |
fragment length analysis3ca2bb5b-fb55-46ab-ad08-bda7edacdbab |
fragment-based X-ray screening7d0b0e8d-0de8-46a9-a5ea-9cb761ada461 |
FRAPb7a49f6a-bcf1-48d9-8a21-9ba4e88e837b |
freeze-drying39724297-ae46-4293-8850-47b9b3049d3d |
FRET2a93c7a1-fd96-42ff-a31d-55f80fa752c0 |
GCPbde2d1e0-9b32-4ba8-bab1-976e721039a5 |
gene delivery983d9821-1dcf-495c-8d77-993022f4ee36 |
genetic literacy67c73694-99de-4789-bee9-52509e008eb3 |
genome editingc0e802a2-b3bf-4d72-b0ba-0b2faef6c7a8 |
genotoxicityafe6fdfc-8fe1-400b-8ea4-06069494da3f |
GIST80d74a39-d94b-4bda-a979-bc7d4fffde79 |
glycanf57fb4d5-f2d9-4ab0-8f65-4e3f916e1691 |
glyco-engineeringd47ac4fc-530f-4758-b445-b5a49742c812 |
grantsa4bb0619-791f-47fe-9722-1ecd12bc8a2f |
growth factors0d732be0-4cac-4fb3-b8f0-1ebea7adcbcf |
gut1abf2e50-68d6-4caf-a4cd-fcbd130b2e76 |
HDAC6be751e27-d43d-4b44-bd57-11de4408586c |
head & neck cancer6b54824d-cb16-4a30-b09f-5ca46aec7cd6 |
health care policy86969910-f3ff-436b-8a30-28048facc371 |
health literacy67c73694-99de-4789-bee9-52509e008eb3 |
health-service innovationa9ba06fd-e47a-4312-97c6-d780df53237c |
hearing loss78373034-e3b4-41af-96f5-b0903b46832f |
Hedgehog signaling19e1e2da-0f1f-4e9a-9d82-25a1bbd6215a |
hemangiosarcoma2ab1fb59-09b2-48dc-a836-9e82e64eeb9e |
hematology7d490880-f428-44b9-8bdb-c3106f53171a |
Hematopoietic stem cellsd97b6b12-94b9-4a4a-a770-f406df19972d |
Hepatocellular cancercbd9d6f1-56da-4a1a-a801-1ee71eff4ea4 |
heterocyclescf8ccdd1-e0c7-4961-be02-d58aa9d646a5 |
HIFUb486896d-fb50-42c9-b223-833e050465f8 |
high intensity focused ultrasoundb486896d-fb50-42c9-b223-833e050465f8 |
high performance computing38166c15-a34f-42d2-8fb8-603fcbb079f1 |
high-content imaging581f372a-8da8-4df8-9517-7a5454dc35cc |
high-content imaging581f372a-8da8-4df8-9517-7a5454dc35cc |
HIRUZed46bc11-09af-45f3-b521-3451df4fd2cf |
histochemistryd24576e8-1c64-426f-aa8e-0c01d3059d25 |
histology2e40e12e-d99a-4901-a6eb-c6a5008bc6ba |
histone adductomics932b4d07-866d-4251-8d01-f7d4326e6e39 |
HIV20e9d772-4e30-43da-9a55-ef06ca22ccb3 |
holistic assessmentefa6e64b-8839-47a4-801b-f4ba91736af3 |
hormonal treatmentb2dd900b-eb7e-4626-89b5-480db2b16990 |
Hybridoma81bdab74-da7c-4aff-9e13-f3ec5883052e |
hyperproliferationd4d4e077-1e28-496a-8aea-db69e02a9d30 |
i-Motifsc7ed0249-7e1a-41a7-bdbd-c8088aec7250 |
IBDe9c1eb94-c6b6-4951-9eab-a5aafabcd901 |
image processingb7a49f6a-bcf1-48d9-8a21-9ba4e88e837b |
imatinibcab3d630-f9e8-4fed-9538-2179d1c32256 |
immune cell development90b68a30-1c91-4f38-80f2-2d6218764e5b |
immune recoveryb4459e1b-67af-4d12-83b9-4c37315c7ddf |
immuno-oncologyaa7da943-090f-4bcc-b150-57d3b93ee7f1 |
Immunoassays30520d4c-9ba6-4d94-88a0-242ec3da47ac |
immunochemotherapy85bdda86-f13e-45e4-bf50-30266abec561 |
Immunoconjugates77fb7ffb-7d7d-4cd1-8e6a-8fe73ac9c35e |
immunodeficiency97d82e13-afba-430a-9917-d4c448aefcfc |
Immunodeficient mice9892209a-37b7-441c-b5a7-55ddf1fe422e |
immunoeditinga4699f5b-9ea6-4e75-bf4a-582a80db41a3 |
immunology5b97c928-0e0b-49e0-a1c0-a9c6092b6c4a |
immunometabolism63cd1123-96c1-46c3-93a2-ed7d7a86663e |
immunomicsb95bbf2a-1e6d-4244-8526-a3491e816e8c |
immunopeptidomicsec130b37-a723-4382-b024-505f13808311 |
immunospheroidsc37a3ec3-fbfa-4a98-ad45-0ee748c8deae |
imprinting08f502e8-4e76-48cc-a4b4-78ec96e31c40 |
in vivo modelddf4d83d-1ad3-477e-a56d-2a1662f2ec1f |
infectious diseasesc47df9cf-8843-4771-a0e4-129faa12322a |
inflammatory bowel diseasee9c1eb94-c6b6-4951-9eab-a5aafabcd901 |
informal caregivers32678b2d-dd90-461b-aefe-3e8ea7beb7d9 |
iNKT cells63cd1123-96c1-46c3-93a2-ed7d7a86663e |
iNKT ligandsc45ca62a-2e70-4b39-95be-8958af394b3a |
intact protein mass specd47ac4fc-530f-4758-b445-b5a49742c812 |
integrative genomicsf5841ca1-8230-4144-b3e6-24b4c853584d |
interactions2ae76a31-1840-4b37-8b77-1549567d3f16 |
interactive data visualization0d920f63-13fc-4fac-8715-1dfcc9e0bbe2 |
Interferons035df82b-8bd8-4ae6-955b-1e1d98559bb9 |
invadopodia781bfc36-b5ea-4577-9db5-d7bfa72f1b9c |
invadosomes781bfc36-b5ea-4577-9db5-d7bfa72f1b9c |
iron metabolismc37a3ec3-fbfa-4a98-ad45-0ee748c8deae |
isotope ratio87a47972-f22d-4e1a-bd75-4cbb405b6667 |
keratinocytesbe7d37b1-9437-43fa-aa29-7df738b7067e |
kidney transplantationb252c086-cbe7-4422-8919-b01f3ccf7e83 |
Koninklijke Academie Geneeskunde28a8fcc1-dd20-4783-a608-cc6e3fbcdcd2 |
Koninklijke Academie Geneeskunde28a8fcc1-dd20-4783-a608-cc6e3fbcdcd2 |
lab-on-a-chip3413be51-b39b-4357-adfb-46da63646f7c |
label-free detectiond5d420a9-7331-49af-adfa-346645c36fc5 |
laparoscopy12e57e1b-a1ce-40c1-91bc-bd5b8258ceab |
laparotomy12e57e1b-a1ce-40c1-91bc-bd5b8258ceab |
large animal12e57e1b-a1ce-40c1-91bc-bd5b8258ceab |
large animal modelsdb61fa33-9f45-4a8f-a8cb-3556b044cd9f |
LCMc4e905b7-442a-44db-b8a0-c0a6d846626b |
licensing26fd97d7-6e03-4c85-a3db-59458431e5ca |
lichen sclerosus66b45939-48e4-478b-97f4-4216326b839d |
light scatteringe90fd5fb-f926-40be-ae71-271636872a24 |
liquid biopsyae02d6f6-9f8a-4b90-a59c-a5faaa349a8c |
live cell2a93c7a1-fd96-42ff-a31d-55f80fa752c0 |
liver25551bf1-8dcc-4473-876a-b7d1c6f27f75 |
liver steatosis2e3b9e92-19db-4a1b-beb6-33c54d6c7322 |
LMBP81bdab74-da7c-4aff-9e13-f3ec5883052e |
local therapy8021d494-9112-45b8-9e3f-05581f7a217f |
logo0a03b7fa-e747-4048-bf74-0af0b96e2e24 |
long-read sequencing13dbedcb-e33e-4366-bca2-f089b2693cd4 |
Luminex30520d4c-9ba6-4d94-88a0-242ec3da47ac |
lung cancer model802be9c2-c90c-432c-975c-64290dfe0dc4 |
lung surfactantfb11dd20-e25d-4653-bfb6-7c56d0845d7d |
lymphedema2a70bdd0-8c97-40f1-b81c-89323a9289c5 |
lymphoid malignancies3ecbcdb1-5a94-489d-bc19-a3ee2e77fca0 |
lyophilization39724297-ae46-4293-8850-47b9b3049d3d |
lysosomesfb11dd20-e25d-4653-bfb6-7c56d0845d7d |
MACSima581f372a-8da8-4df8-9517-7a5454dc35cc |
magnetic nanoparticlesfd7f596b-a5e5-44f0-a18b-fbe7c6a2959b |
malnutrition2f1e91d3-7761-4c24-8325-39af1d9d9919 |
mammalian protein expressiond47ac4fc-530f-4758-b445-b5a49742c812 |
mammography31a02354-6dda-4b5a-9dad-b9425e033956 |
MDGa2f406b3-8d0b-426b-aeee-3b0822313669 |
mechanistic biology871ab459-ce5b-4263-8996-67e59314dea3 |
medical devices5fa50a5f-a39b-42bf-b28f-21ad82432acb |
medical imaging5fa50a5f-a39b-42bf-b28f-21ad82432acb |
Melanocyte9280ead3-62c7-46fc-bf20-30679689d708 |
meningioma6de29e09-f0c4-49f1-ad14-cdfb4f32d1d7 |
mental health carebd9e9490-4b48-4285-85c0-ef67de5a3a7c |
mentoring programe49a8b86-c80b-4179-ac2e-e37bfcc4a703 |
mesenchymal stem cells47a489d1-f541-4a63-9aad-370b024e7913 |
mesothelial-mesenchymal transition581811ab-d986-4928-b7eb-619b00e6ec27 |
metabolic fingerprinta487ed86-3872-4887-9bf0-9b606359f466 |
micro-PET-CTb49daf39-67dd-428b-8161-39a95f843bc2 |
microbial metabolitesd55b9ab4-6ced-4f3c-8f0c-06838fcc285f |
micronucleus06092b29-82db-49e9-9a17-cccc295dcbd7 |
microreactorcf8ccdd1-e0c7-4961-be02-d58aa9d646a5 |
microspheres7438f30f-f58c-49cd-8410-254442984b74 |
midostaurincab3d630-f9e8-4fed-9538-2179d1c32256 |
migration parametersdbe22699-238b-46d5-91c4-8d916c5882a1 |
minimal residual disease7c3bd6c4-34ac-4af9-a0d0-2b5f4e00be1a |
MMT581811ab-d986-4928-b7eb-619b00e6ec27 |
MOC012cdf7a-7705-4f84-abcd-5196249333da |
MOC012cdf7a-7705-4f84-abcd-5196249333da |
models of metastasis8fda57b9-0387-415d-8497-d5cfbaedce78 |
modular cloning0c349a67-fcd4-4b75-acac-ddc2f809fe48 |
molecular diffusionb7a49f6a-bcf1-48d9-8a21-9ba4e88e837b |
molecular pathology6da25e4c-d28b-4871-9a60-96e3735f1c23 |
MPS2212930f-65af-4e11-ae67-a0621ab8aa24 |
MRD7c3bd6c4-34ac-4af9-a0d0-2b5f4e00be1a |
MRI6d1d6630-bc44-400b-9b88-a14ce9bed562 |
mRNA4f3d88e1-961d-4a72-b76e-6fda40aebb91 |
MSIb3dfb72b-c367-4594-bd3a-297c22bae435 |
Mucositis50c181b6-24d2-48a1-ba17-60ed441f78e2 |
multidisciplinary care321f6001-6d12-4990-af65-758745442c4f |
multiphoton microscopy7b0d84b5-a69d-4fb9-bbd2-05746246951c |
mutation screening39e6c9d5-592a-42a6-9896-b3e3a5033a5a |
mycotoxins2486504b-f8e9-4982-81c9-6d26fd08e664 |
myelodysplasiabcedba3c-bea0-4543-8d9d-22274d068ee2 |
N-glycosylation7dc8b10a-0477-40b9-8f77-f33f21bbd592 |
nanoclusterse46240f3-bdb2-468e-bf00-92f53b82e7de |
nanocompositese46240f3-bdb2-468e-bf00-92f53b82e7de |
nanocrystald5a78042-e231-4860-8736-0136e6606fbb |
nanomagnetismfd7f596b-a5e5-44f0-a18b-fbe7c6a2959b |
nanoparticlee90fd5fb-f926-40be-ae71-271636872a24 |
nanoscopyb7a49f6a-bcf1-48d9-8a21-9ba4e88e837b |
nanowired5d420a9-7331-49af-adfa-346645c36fc5 |
necrosis6d1d6630-bc44-400b-9b88-a14ce9bed562 |
necrosis6d1d6630-bc44-400b-9b88-a14ce9bed562 |
NESPRc18a7876-8898-4b78-a6b4-37c3b71b409e |
NET80d74a39-d94b-4bda-a979-bc7d4fffde79 |
network analysis8386dfe1-bbf1-4b9a-8186-c3b8cc3914a3 |
neuroendocrine tumors80d74a39-d94b-4bda-a979-bc7d4fffde79 |
neuroimaging608d38ab-1131-458e-9fbd-c7197a634932 |
new chemical entitiesbe751e27-d43d-4b44-bd57-11de4408586c |
NKT cells63cd1123-96c1-46c3-93a2-ed7d7a86663e |
non-alcoholic steatohepatitis8ef8b9b2-5564-4c21-bea1-7f79fe4fbf8b |
non-thermal plasma technologye465221b-1b36-4baf-a06c-e4262d07e75e |
noradrenaline1f24645c-afcf-487c-a9c2-1422e960fb45 |
NTAb7a49f6a-bcf1-48d9-8a21-9ba4e88e837b |
nucleic acide396c90f-6fca-47dc-a8c1-089d9e79ed0d |
nucleic acid sensorsae5d7248-1185-434a-86ed-525f7f40b20a |
nucleic acid therapyfebd8167-1e51-4afc-bcdc-af13ecd9fadc |
nucleoside analoguesc45ca62a-2e70-4b39-95be-8958af394b3a |
obesity2e3b9e92-19db-4a1b-beb6-33c54d6c7322 |
oesophageal cancer2f055824-349e-4c91-a171-d2792a7a8fd6 |
oligonucleotide synthesis4a078560-fb27-4c2e-a0b6-0d82f945f97e |
oncogenic bacteria80274e70-3082-4f04-80ef-ba643dc4ba77 |
oncogenic receptors871ab459-ce5b-4263-8996-67e59314dea3 |
oral anticancer drugs0416a498-8e41-4f35-91b4-ac91819d3fb7 |
oral cancerbf8ffde7-2876-4834-99f7-1bcf45dcfda6 |
ORFeome81bdab74-da7c-4aff-9e13-f3ec5883052e |
outcomes research25ac1c5d-63fe-4048-a288-468df4d5b49d |
oxygen sensing034467ce-4207-43fd-a77d-a994385009f3 |
PAP smeara78261ce-e0b7-4e1d-9410-53bbb6f9f587 |
paragangliomab1e4fee9-9829-4651-bee1-cdeae1f5b59c |
PARP inhibitora799fb18-b5b0-444d-b04e-6e102f1ff001 |
particles5790b7b7-e5e7-4f80-a7a2-1a00eb586bcd |
partnering issuescdef93ab-9b0e-48ff-8b07-9b11d197ea4f |
partners66898326-daf8-480f-b97a-1e4873129622 |
partnership grants197fe4c6-1c5b-4a00-bf01-68a0d9bf970d |
partnership grants197fe4c6-1c5b-4a00-bf01-68a0d9bf970d |
patent81bdab74-da7c-4aff-9e13-f3ec5883052e |
patient and public involvementcb457b9b-e168-4418-a90d-c3d03a2e961d |
patient empowermented46bc11-09af-45f3-b521-3451df4fd2cf |
patient empowermented46bc11-09af-45f3-b521-3451df4fd2cf |
patient participationed46bc11-09af-45f3-b521-3451df4fd2cf |
patient treatmente8898110-af14-4002-8866-be53e0d20fab |
pDNA4f3d88e1-961d-4a72-b76e-6fda40aebb91 |
pediatric cancerc421e39c-4126-4148-a33f-72f9e1a8e888 |
penile cancer783bc9ef-fd51-4a53-8ef1-dd463272dbb5 |
Peptide nucleic acidsc7ed0249-7e1a-41a7-bdbd-c8088aec7250 |
peptide synthesis4a078560-fb27-4c2e-a0b6-0d82f945f97e |
Personalized cancer therapy58d4ed08-08b9-4e16-8142-a95ff0561bf6 |
personalized medicine58d4ed08-08b9-4e16-8142-a95ff0561bf6 |
PET6d1d6630-bc44-400b-9b88-a14ce9bed562 |
pharmaceuticals5c5d8dac-b00a-4849-a365-8ada3335fac3 |
pharmaco-epigenetics76595a9a-0ce0-4af2-b3af-8d2ef2ccee29 |
pharmacodynamics5c5d8dac-b00a-4849-a365-8ada3335fac3 |
Phenotype-switching0a9c9fbb-64c7-4a91-b276-0c06eeaefdca |
pheochromocytomab1e4fee9-9829-4651-bee1-cdeae1f5b59c |
photoactivity probes4a078560-fb27-4c2e-a0b6-0d82f945f97e |
photosensitizerd589b6cb-1a45-4031-9100-4edffeed2c59 |
phototherapya8a58b8c-87af-43fd-a92d-0b47e6711cb8 |
Pig12e57e1b-a1ce-40c1-91bc-bd5b8258ceab |
plasma biomarkerae02d6f6-9f8a-4b90-a59c-a5faaa349a8c |
plasma proteins3fff77ff-0d74-4ad7-a332-ad3671d597dd |
plasma RNA sequencing2b9a0419-762c-4fca-8685-b5fd74c1620e |
plasma-based cancer treatmente465221b-1b36-4baf-a06c-e4262d07e75e |
plasma-treated hydrogelse465221b-1b36-4baf-a06c-e4262d07e75e |
plasma-treated liquidse465221b-1b36-4baf-a06c-e4262d07e75e |
plasmid81bdab74-da7c-4aff-9e13-f3ec5883052e |
platinum-induced ototoxicity78373034-e3b4-41af-96f5-b0903b46832f |
platinum-induced vestibulotoxicity78373034-e3b4-41af-96f5-b0903b46832f |
pleiotropic treatment effects17a32f31-79bc-4621-9da0-cedb7249b090 |
polymer-drug conjugates983d9821-1dcf-495c-8d77-993022f4ee36 |
Polyphenol33ce5ac9-f4ec-4c9d-aa4d-f02140a4fc41 |
polyposis syndromes80d74a39-d94b-4bda-a979-bc7d4fffde79 |
portfolio buildingcdef93ab-9b0e-48ff-8b07-9b11d197ea4f |
positional proteomics3fe7c213-6bd7-4d9a-ad16-5fd8b5280afd |
post-mortem tissues0d920f63-13fc-4fac-8715-1dfcc9e0bbe2 |
pregnancyc2a0faa8-3d1d-4f87-a90e-50ee4be1237e |
prehabilitation84a3f996-157d-4448-966b-959e64534ce5 |
prone crawl position76bf3e5c-303c-4aaf-9944-a7c151348001 |
prone positionadf985df-d11d-4704-946c-7ccc898f5e6d |
proportionate universalisme086a0d3-5760-4e8e-b471-a613a169c4b1 |
prostate cancerf7158e84-6da7-4f0d-8605-5c1dd12f65ff |
prostate-specific antigend5d420a9-7331-49af-adfa-346645c36fc5 |
prosthesis0e832218-878a-415e-af14-46477e50d1d0 |
protein chemistry83df5828-5960-4079-a59c-08c76245ec77 |
protein engineering538f55b0-5f56-4515-a4c8-f4f495667f04 |
protein technologybf408afd-738e-46db-8843-b8da06b6c0ef |
protein-DNA conjugates4a078560-fb27-4c2e-a0b6-0d82f945f97e |
Proteoglycansceb726ee-d395-4b26-a123-a136f12a66aa |
proton therapy158f5720-02af-4c9c-844e-630e449bf1fb |
psychology5fcf9f57-b728-4cd3-a4de-522b26ce84ca |
psychosociaal oncologisch team5fcf9f57-b728-4cd3-a4de-522b26ce84ca |
psychosocial caree8898110-af14-4002-8866-be53e0d20fab |
psychosocial researchac005421-5655-4c9d-ae66-7a91379d451c |
qPCR1cd4c65d-2cea-42b1-9fa2-b4400389b660 |
quality assurance25ac1c5d-63fe-4048-a288-468df4d5b49d |
quantificatione396c90f-6fca-47dc-a8c1-089d9e79ed0d |
quantitative metabolite profiling87a47972-f22d-4e1a-bd75-4cbb405b6667 |
rabbit12e57e1b-a1ce-40c1-91bc-bd5b8258ceab |
radioembolizationdb100c91-781b-4b3f-bae8-fb35c8023ef2 |
radiogenomics06092b29-82db-49e9-9a17-cccc295dcbd7 |
radiotherapy00fe3c2a-8277-43dd-bd8b-4f64e1dfe57a |
rare diseases571df913-334d-451d-8e90-1e8f76469c2a |
Reactive oxygen and nitrogen speciese465221b-1b36-4baf-a06c-e4262d07e75e |
Receptor035df82b-8bd8-4ae6-955b-1e1d98559bb9 |
receptor tyrosine kinase871ab459-ce5b-4263-8996-67e59314dea3 |
receptors871ab459-ce5b-4263-8996-67e59314dea3 |
recombinant protein0c349a67-fcd4-4b75-acac-ddc2f809fe48 |
recombinant proteins0d732be0-4cac-4fb3-b8f0-1ebea7adcbcf |
reconstruction prostesis0e832218-878a-415e-af14-46477e50d1d0 |
Regenerative and neoplastic inflammation964e2443-cb66-4a87-9976-59c43581be7f |
regulatory network inferencec43e2393-12d1-4496-948d-73f18301299a |
regulatory T cells2f7048b6-69b9-4a86-ae3c-6466056615a2 |
REIMS95d8a83f-7541-4eaa-9492-027732232119 |
repurposingfb11dd20-e25d-4653-bfb6-7c56d0845d7d |
research & innovation management38533ce3-d5eb-4453-b152-ce5f74b2a51b |
retinoblastoma19e1e2da-0f1f-4e9a-9d82-25a1bbd6215a |
Reverse Genetics9c357f9e-74b4-4376-8dbb-69e9be836e57 |
rhabdomyosarcoma783bc9ef-fd51-4a53-8ef1-dd463272dbb5 |
RNA delivery419523be-735f-477b-b79d-0a1220531361 |
RNA quality3ca2bb5b-fb55-46ab-ad08-bda7edacdbab |
RNA quantification3ca2bb5b-fb55-46ab-ad08-bda7edacdbab |
RNA-protein interactions687460a6-6b8c-4542-8890-5b37c364ca8f |
salivary gland tumorsb6450923-4682-4ef4-bcad-f72678bf799c |
sarcomagenesis67fefbba-e2ee-4ddc-8df1-9f3908ae5934 |
scanxietya9ba06fd-e47a-4312-97c6-d780df53237c |
science communication3544ed80-3199-4dd8-ba77-cf4ebd259c84 |
science communication3544ed80-3199-4dd8-ba77-cf4ebd259c84 |
screeningfb11dd20-e25d-4653-bfb6-7c56d0845d7d |
screening tool development79f98229-eec4-4c6b-be1a-b94331fab29f |
secondary cancera29ae075-605e-4a3a-9ac6-0f9955fe1bb8 |
Selective glucocorticoid receptor modulator SEGRMbd84c7c7-2a89-4ef5-aba5-3c7c30e8ace7 |
self-assembling structurescac32cf4-940b-43c3-a814-9ac6ce3ebb9b |
sequencing library size analysis3ca2bb5b-fb55-46ab-ad08-bda7edacdbab |
shallow whole genome sequencing69470811-eb43-48dd-aad6-bda5e968194c |
sheep12e57e1b-a1ce-40c1-91bc-bd5b8258ceab |
shRNA81bdab74-da7c-4aff-9e13-f3ec5883052e |
side effects608d38ab-1131-458e-9fbd-c7197a634932 |
single cancer celle4d7ee57-774c-4138-90de-11f45d1d3e64 |
single cell epigenomicsbfea94a5-a5bb-4594-9867-d4eddd938524 |
Single Particle Trackingde88e604-babd-4d99-92c1-3240583feabb |
sizee90fd5fb-f926-40be-ae71-271636872a24 |
size and density based separationb109a4bd-eedb-4095-9464-7ea88115ca3b |
size-based chromatographyf513ad63-0841-49d2-ac0a-74b5222a0f41 |
sizinge396c90f-6fca-47dc-a8c1-089d9e79ed0d |
Skin cancer0715ab91-ca84-4cf7-bbd2-ed6494e7d7f8 |
skin cancer imaging40966da4-5fb3-43ad-98d1-4e2d8f5c7def |
sleep2a05fdbe-bb51-4462-a049-f76e8b71f228 |
Small moleculesfb11dd20-e25d-4653-bfb6-7c56d0845d7d |
smartphone app78c82f7f-1d8c-45f5-b098-f9238c8f1cab |
social network66898326-daf8-480f-b97a-1e4873129622 |
somatic variant calling8386dfe1-bbf1-4b9a-8186-c3b8cc3914a3 |
spatial biology581f372a-8da8-4df8-9517-7a5454dc35cc |
spatial epigenomicsbfea94a5-a5bb-4594-9867-d4eddd938524 |
spatial proteogenomics5b37c56b-7ec4-4ab4-bb5c-e5730180863c |
spatial proteomics581f372a-8da8-4df8-9517-7a5454dc35cc |
spectroscopyb6450923-4682-4ef4-bcad-f72678bf799c |
spinning disk microscopyb7a49f6a-bcf1-48d9-8a21-9ba4e88e837b |
SPTb7a49f6a-bcf1-48d9-8a21-9ba4e88e837b |
statistical inferenced6406e85-6bac-4dd8-bb70-7316a0702599 |
Stem cell angiogenesiscbd9d6f1-56da-4a1a-a801-1ee71eff4ea4 |
stem cell differentiation2a93c7a1-fd96-42ff-a31d-55f80fa752c0 |
subcellular5d800536-8331-451d-8645-12eb1e29a6a4 |
subtyping00150295-523e-4e2a-8e6e-3036a5987de5 |
surface-guided radiotherapy393c9041-dd9d-42df-89b4-44125455fbdb |
sustainabilityefa6e64b-8839-47a4-801b-f4ba91736af3 |
swallowing82eba68f-ab9c-4e78-80b8-b47056467ec4 |
symptom clusters84a3f996-157d-4448-966b-959e64534ce5 |
synthethic biology0c349a67-fcd4-4b75-acac-ddc2f809fe48 |
synthetic chemistry8f91360c-3d0b-484a-ac47-833f388880c5 |
synthetic datad6406e85-6bac-4dd8-bb70-7316a0702599 |
synthetic lethalityaeb71553-6f43-40bc-824b-7d58e16454c8 |
synthetic methodologycf8ccdd1-e0c7-4961-be02-d58aa9d646a5 |
systems biology7e1d6d23-c16f-44c1-9770-2e73d28fca12 |
T cell receptor7d490880-f428-44b9-8bdb-c3106f53171a |
T lymphocyteb4459e1b-67af-4d12-83b9-4c37315c7ddf |
T-ALLaa7da943-090f-4bcc-b150-57d3b93ee7f1 |
targeted protein degradation26afce6f-df74-4e90-a0de-d3bb1b5baad4 |
TCR transgenic T cellsb28caba7-a119-4594-ab28-080a20b68a59 |
technology transfer38533ce3-d5eb-4453-b152-ce5f74b2a51b |
telomerase inhibitionc7ed0249-7e1a-41a7-bdbd-c8088aec7250 |
terminal illness321f6001-6d12-4990-af65-758745442c4f |
the cancer genome atlas38166c15-a34f-42d2-8fb8-603fcbb079f1 |
therapeutic drug monitoringcab3d630-f9e8-4fed-9538-2179d1c32256 |
therapeutic enzymes6351d995-f631-477b-95c4-082338751c00 |
Therapeutic target identification022935e8-9643-4995-af9a-c5521ada8ecd |
therapy response6d1d6630-bc44-400b-9b88-a14ce9bed562 |
therapy response monitoring7c3bd6c4-34ac-4af9-a0d0-2b5f4e00be1a |
thermal proteome profiling4c58e73b-9e90-45fe-a80f-38bd2fc3fdd7 |
thermodynamics4b478354-3527-448c-b40f-c472001e4fbd |
thymus5aad7365-8317-4098-8b46-92b24cb1faca |
thymus seeding precursorsde702a1c-bc0b-4d51-8277-f7b9a54a8b79 |
tinnitus78373034-e3b4-41af-96f5-b0903b46832f |
tissue clearing7c96e8e8-1843-4fb9-acf5-a0a162a140d8 |
tissue printing341a7c8c-2104-4f8a-8fec-8423a4d1c301 |
tissue spheroids621c597a-2f4d-46f4-a4b2-3b9e48fafdc7 |
tissue-leakage proteins00887872-ccd0-4535-9fea-75c827bc3b60 |
TLR agonists1f62aba6-32e2-4bf7-b768-6d80bf33665b |
TNF82fc6f79-4140-4f91-abe8-c3c332383e1a |
tracerfd5cf45a-fdfb-4b26-be23-e14370ca24f4 |
transarterial therapydb100c91-781b-4b3f-bae8-fb35c8023ef2 |
translational medicined3f8a22e-500c-41d3-a547-66a4eb33f2c6 |
translatomics6e42b520-1db4-4727-a8b2-4df73236b57a |
transposable elements6c635aa8-c37f-4795-8ba2-fbbc997566e4 |
tumor cell vaccined5679322-c470-4903-9c0c-f5ec7c5ab2ac |
Tumor initiation and progressione185bf8a-faaf-47fd-bc89-cbce08520d02 |
tumor penetrationde88e604-babd-4d99-92c1-3240583feabb |
tumor targeted deliveryd5679322-c470-4903-9c0c-f5ec7c5ab2ac |
tumor-draining lymph node9f3544d6-6585-41a1-8b62-df72859639e3 |
tumour prophylactic vaccination model8c79b65e-110d-4ff6-a877-28eb00f15311 |
ultrasound contrast agents14e0ffcf-79ba-40d8-bb59-f95b3e371d24 |
urothelial cancere0efcb39-a944-41f5-ad48-00e1eb0ee0b8 |
uterine cancer41131d7d-858b-4076-bbc8-faefd821fcbd |
UV/Vis absorbance6ec9a11f-76ab-4326-aa4c-172891022a17 |
vaginal cancer41131d7d-858b-4076-bbc8-faefd821fcbd |
vapor nanobubblesb5d3f972-9bfa-4699-9326-8d2af9bb4926 |
vascular corrosion casting89edd557-2ac6-44fe-8ad3-171cf78b0255 |
vascular disruptive agent316d21f3-0524-429b-b1b4-227c59b6fe9e |
vascularisationa07afa82-8f89-4325-b76a-8415bf3bbb63 |
vesicle traffickingf513ad63-0841-49d2-ac0a-74b5222a0f41 |
virally induced cancer25882b4e-45da-44d2-8663-0f5fb93e1907 |
virtual surgical planningb6450923-4682-4ef4-bcad-f72678bf799c |
virus-induced cancer4f1b3501-72d9-477f-a587-8c01183f40db |
virus-induced leukemia4f1b3501-72d9-477f-a587-8c01183f40db |
virus-induced lymphoma4f1b3501-72d9-477f-a587-8c01183f40db |
virus-like particles26294723-5a9e-47c9-99d5-d89bb08904b9 |
volatile organic compoundsd312dc3e-593c-4c21-9307-2bfd5beca822 |
vulvar cancer41131d7d-858b-4076-bbc8-faefd821fcbd |
WESf3bf3a2f-0448-44b4-b9ec-7011979b1ee1 |
whole transcriptome sequencing13dbedcb-e33e-4366-bca2-f089b2693cd4 |
whole-breast irradiationadf985df-d11d-4704-946c-7ccc898f5e6d |
wound microbiomed4d4e077-1e28-496a-8aea-db69e02a9d30 |
Xenopusc0e802a2-b3bf-4d72-b0ba-0b2faef6c7a8 |
Xenopus tropicalisc0e802a2-b3bf-4d72-b0ba-0b2faef6c7a8 |
Zeb29c357f9e-74b4-4376-8dbb-69e9be836e57 |